Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXW7OL
|
||||
Drug Name |
(Z)-5-{6-[3-(4-Chlorophenyl)-ureido]-2-oxo-1,2-dihydroindol-3-ylidene-methyl}-2,4-dimethyl-1H-pyrrole-3-carboxylic acid
|
||||
Synonyms |
CHEMBL1172421
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C23H19ClN4O4
|
||||
Canonical SMILES |
Cc1[nH]c(\\C=C\\2/C(=O)Nc3cc(NC(=O)Nc4ccc(Cl)cc4)ccc23)c(C)c1C(=O)O
|
||||
InChI |
InChI=1S/C23H19ClN4O4/c1-11-18(25-12(2)20(11)22(30)31)10-17-16-8-7-15(9-19(16)28-21(17)29)27-23(32)26-14-5-3-13(24)4-6-14/h3-10,25H,1-2H3,(H,28,29)(H,30,31)(H2,26,27,32)/b17-10-
|
||||
InChIKey |
RWCSLXSUPQHKBX-YVLHZVERSA-N
|
||||
Target and Pathway | |||||
Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
FL cytokine receptor | Target Info | [1587926] | |||
KEGG Pathway | Ras signaling pathway | ||||
Rap1 signaling pathway | |||||
Cytokine-cytokine receptor interaction | |||||
Endocytosis | |||||
PI3K-Akt signaling pathway | |||||
VEGF signaling pathway | |||||
Focal adhesion | |||||
Proteoglycans in cancerhsa04060:Cytokine-cytokine receptor interaction | |||||
Hematopoietic cell lineage | |||||
Pathways in cancer | |||||
Transcriptional misregulation in cancer | |||||
Acute myeloid leukemia | |||||
Central carbon metabolism in cancer | |||||
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | Angiogenesis | ||||
VEGF signaling pathway | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
Beta3 integrin cell surface interactions | |||||
Signaling events mediated by TCPTP | |||||
SHP2 signaling | |||||
S1P1 pathway | |||||
VEGF and VEGFR signaling network | |||||
Integrins in angiogenesis | |||||
Signaling events mediated by VEGFR1 and VEGFR2 | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.